Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martelli

Showing results (441-450 of 549) with videos related to

Pageof 55
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic diseaseM F Osti, L Agolli, M Valeriani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter studyM Martelli, M Vignetti, P L Zinzani, et al.
Cancer Research|November 18, 2008
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cellsPier Luigi Tazzari, Giovanna Tabellini, Francesca Ricci, et al.
Tumori|April 30, 1991
Prognostic value of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL)G De Rossi, L Granati, G Girelli, et al.
Leukemia & Lymphoma|October 27, 2006
Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosisH Mossafa, D Damotte, A Jenabian, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Advances in Biological Regulation|December 3, 2014
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasisJames A McCubrey, Stephen L Abrams, Timothy L Fitzgerald, et al.
Oncotarget|August 14, 2012
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levelsDaniela Bressanin, Camilla Evangelisti, Francesca Ricci, et al.
Leukemia|February 19, 2011
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemiaC Evangelisti, F Ricci, P Tazzari, et al.
Haematologica|February 27, 2001
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapyP L Zinzani, M Martelli, M Bendandi, et al.
Pageof 55

Showing results (441-450 of 549) with videos related to

Sort By:
Pageof 55
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic diseaseM F Osti, L Agolli, M Valeriani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter studyM Martelli, M Vignetti, P L Zinzani, et al.
Cancer Research|November 18, 2008
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cellsPier Luigi Tazzari, Giovanna Tabellini, Francesca Ricci, et al.
Tumori|April 30, 1991
Prognostic value of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL)G De Rossi, L Granati, G Girelli, et al.
Leukemia & Lymphoma|October 27, 2006
Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosisH Mossafa, D Damotte, A Jenabian, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Advances in Biological Regulation|December 3, 2014
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasisJames A McCubrey, Stephen L Abrams, Timothy L Fitzgerald, et al.
Oncotarget|August 14, 2012
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levelsDaniela Bressanin, Camilla Evangelisti, Francesca Ricci, et al.
Leukemia|February 19, 2011
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemiaC Evangelisti, F Ricci, P Tazzari, et al.
Haematologica|February 27, 2001
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapyP L Zinzani, M Martelli, M Bendandi, et al.
Pageof 55